Medtronic Loses ICD Market Share, Looks Ahead To U.S. Market Rebound
This article was originally published in The Gray Sheet
Executive Summary
Medtronic is optimistic about a recovery in the implantable cardioverter defibrillator market, despite lower-than-expected sales in its most recent fiscal quarter, reported Feb. 20